11/14/2024
5:14 PM | BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
3:56 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
2:28 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
1:10 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024
3:23 PM | Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
|
11/01/2024
3:24 PM | Sage Therapeutics (Issuer)
Shiferman Gregory L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
3:10 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
3:20 PM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024
10:37 AM | Sage Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/17/2024
6:11 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
5:37 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
6:07 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
5:33 AM | Sage Therapeutics (Filer)
| Form S-3ASR | |
07/31/2024
3:10 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2024
3:15 PM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024
5:39 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
3:57 PM | Federer Jessica (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:57 PM | Barrett Elizabeth (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:57 PM | COLA MICHAEL F (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:58 PM | FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:58 PM | Germano Geno J (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:58 PM | Golumbeski George (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:58 PM | JONAS JEFFREY M (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
11:15 AM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
06/10/2024
8:48 AM | FMR LLC (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
06/06/2024
8:54 AM | Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
04/25/2024
6:15 AM | Sage Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
5:46 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
3:07 PM | Sage Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024
3:10 PM | Sage Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:13 PM | Sage Therapeutics (Filer)
| Form ARS | |
04/19/2024
7:31 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
5:35 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
7:34 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
6:49 AM | Sage Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024
6:20 AM | Sage Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
6:09 AM | RTW INVESTMENTS, LP (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Trump’s Back, but DC’s Coming for Your Money! (Ad) Trump's back in the White House, ready to hit the gas on America's comeback.
He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs.
But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back… Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov |
02/13/2024
4:13 PM | Sage Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/13/2024
5:28 AM | Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024
5:28 AM | BB BIOTECH AG (Filed by)
BB BIOTECH AG (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
9:17 AM | Sage Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/31/2024
4:25 PM | Sage Therapeutics (Subject)
| Form SC TO-I/A | |
01/31/2024
3:50 PM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2024
9:04 AM | Sage Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G | |
01/23/2024
7:13 AM | Sage Therapeutics (Subject)
| Form SC TO-I | |
01/08/2024
5:45 AM | Sage Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:07 PM | IGUCHI KIMI (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | Golumbeski George (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | FRATES JAMES M (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | PAUL STEVEN M (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | Federer Jessica (Reporting)
Sage Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
7:30 AM | Sage Therapeutics (Filer)
| Form DEF 14A | |
12/19/2023
7:32 AM | Sage Therapeutics (Filer)
| Form DEFA14A | |
12/08/2023
8:00 AM | Sage Therapeutics (Subject)
| Form SC TO-C | |
12/08/2023
7:30 AM | Sage Therapeutics (Filer)
| Form PRE 14A | |
12/08/2023
7:30 AM | Sage Therapeutics (Filer)
| Form PRE 14A | |
Free SAGE Stock Alerts